financial post
Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
Financial Post • 4 DAYS AGO
Meesho’s Listing to Test India Investor Appetite After String of Blockbuster Tech IPOs
Financial Post • 4 DAYS AGO
Southeast Asia embraces offshore wind power, as Trump bashes renewable energy
Financial Post • 4 DAYS AGO
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
Financial Post • 4 DAYS AGO
Nepal charges dozens and says corruption inflated an airport’s costs by $74 million
Financial Post • 4 DAYS AGO
